Gyre Therapeutics Stock Market Value
| GYRE Stock | 7.93 0.25 3.26% |
| Symbol | Gyre |
Gyre Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gyre Therapeutics. If investors know Gyre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gyre Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.662 | Earnings Share 0.04 | Revenue Per Share | Quarterly Revenue Growth 0.199 | Return On Assets |
The market value of Gyre Therapeutics is measured differently than its book value, which is the value of Gyre that is recorded on the company's balance sheet. Investors also form their own opinion of Gyre Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Gyre Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gyre Therapeutics' market value can be influenced by many factors that don't directly affect Gyre Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gyre Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gyre Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gyre Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Gyre Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gyre Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gyre Therapeutics.
| 12/21/2025 |
| 01/20/2026 |
If you would invest 0.00 in Gyre Therapeutics on December 21, 2025 and sell it all today you would earn a total of 0.00 from holding Gyre Therapeutics or generate 0.0% return on investment in Gyre Therapeutics over 30 days. Gyre Therapeutics is related to or competes with Anavex Life, Erasca, CytomX Therapeutics, MBX Biosciences, MoonLake Immunotherapeuti, Astria Therapeutics, and Keros Therapeutics. Gyre Therapeutics is entity of United States More
Gyre Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gyre Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gyre Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.35 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 28.29 | |||
| Value At Risk | (5.03) | |||
| Potential Upside | 5.22 |
Gyre Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gyre Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gyre Therapeutics' standard deviation. In reality, there are many statistical measures that can use Gyre Therapeutics historical prices to predict the future Gyre Therapeutics' volatility.| Risk Adjusted Performance | 0.0106 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0032 |
Gyre Therapeutics Backtested Returns
At this point, Gyre Therapeutics is somewhat reliable. Gyre Therapeutics holds Efficiency (Sharpe) Ratio of 0.0204, which attests that the entity had a 0.0204 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Gyre Therapeutics, which you can use to evaluate the volatility of the firm. Please check out Gyre Therapeutics' Downside Deviation of 3.35, risk adjusted performance of 0.0106, and Market Risk Adjusted Performance of 0.0132 to validate if the risk estimate we provide is consistent with the expected return of 0.0776%. Gyre Therapeutics has a performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.99, which attests to possible diversification benefits within a given portfolio. Gyre Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Gyre Therapeutics is expected to follow. Gyre Therapeutics right now retains a risk of 3.8%. Please check out Gyre Therapeutics value at risk, as well as the relationship between the skewness and day median price , to decide if Gyre Therapeutics will be following its current trending patterns.
Auto-correlation | 0.01 |
Virtually no predictability
Gyre Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Gyre Therapeutics time series from 21st of December 2025 to 5th of January 2026 and 5th of January 2026 to 20th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gyre Therapeutics price movement. The serial correlation of 0.01 indicates that just 1.0% of current Gyre Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.01 | |
| Spearman Rank Test | -0.83 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Gyre Therapeutics lagged returns against current returns
Autocorrelation, which is Gyre Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Gyre Therapeutics' stock expected returns. We can calculate the autocorrelation of Gyre Therapeutics returns to help us make a trade decision. For example, suppose you find that Gyre Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Gyre Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Gyre Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Gyre Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Gyre Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Gyre Therapeutics Lagged Returns
When evaluating Gyre Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Gyre Therapeutics stock have on its future price. Gyre Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Gyre Therapeutics autocorrelation shows the relationship between Gyre Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Gyre Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Gyre Therapeutics is a strong investment it is important to analyze Gyre Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gyre Therapeutics' future performance. For an informed investment choice regarding Gyre Stock, refer to the following important reports:Check out Gyre Therapeutics Correlation, Gyre Therapeutics Volatility and Gyre Therapeutics Alpha and Beta module to complement your research on Gyre Therapeutics. For information on how to trade Gyre Stock refer to our How to Trade Gyre Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Gyre Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.